Founded company in 2019.

 

Responsibilities include overseeing the strategic vision and mission of VerdePharm, LLC and its sub-companies.

 

25 years of pharmaceutical commercial experience. Offers specialist expertise in the establishment of oncology biotechnical organizations, developing robust marketing strategies and clear roadmaps for commercial success. Operates effectively in both PE-backed early-stage firms and in mature global enterprises via a targeted focus on best practice client engagement to increase revenue and shareholder value.

Jesse Z.

Hollingsworth

FOUNDER, CHIEF EXECUTIVE OFFICER,

CHAIRMAN OF THE BOARD

Responsibilities include the design and implementation of business operations,
the establishment of VerdePharm's culture and company vision, and the
execution of the executive team's initiatives and objectives.

​

25 years of executive experience in the investment management, venture capital, and alternative investment industry at large financial institutions such as JPMorgan and Morgan Stanley, as a founding member of two successful start-up hedge funds, and as a Product Group Director for a technology company.

​

Well versed in the intricacies of seed funding, in addition to the organizational, financing, and revenue generating requirements of early stage companies.

George

Raupp

CHIEF OPERATING OFFICER,

​

Responsible for shaping and delivering an integrated commercial strategy, driving business growth, and financial performance for the entire VerdePharm portfolio

​

25+ years of executive commercial leadership roles in strategy, sales, business development, marketing, and operations at Fortune companies like IQVIA, Cardinal Health Specialty GPO, AmerisourceBergen Specialty GPO, Tyco International to start-ups like NantHealth, IntegraConnect, and CompanionDx Reference Lab.

​

B.S. Pharmacy from the University of Sciences in Philadelphia.

 

Extended business education at University of Notre Dame and Tulane University

Nikko 

Khazana, R.PH.

CHIEF COMMERCIAL OFFICER,

​

Founder and CEO of Horvath & Giacin, P.C. an accounting firm based in Pennington, NJ offering both accounting and auditing services to clients in over 10 countries.

​

15+ years of capital raise and seed funding experience for various institutions starting with The Bank of Princeton in 2007, followed by a fintech company acquired by Principal Financial Group, and a stem cell research company based in Hong Kong.

​

Over 20 years of experience structuring business mergers and acquisitions for clients in the financial, real estate, manufacturing and service industries.

John 

Horvath

CHIEF FINANCIAL OFFICER,

​